CVKD
Cadrenal Therapeutics, Inc.
1.20$
-4.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.5% | -17.3% | -22.6% | -14.3% | +116.3% | -21.4% | -24.8% | -31.6% | +5.8% | -33.9% | +95.3% | |
| – | -8.5% | -17.2% | -22.5% | -14.2% | +116.4% | -21.4% | -24.8% | -31.7% | +5.9% | -33.9% | +95.6% | |
| – | -7.8% | -21.9% | -23.3% | -13.4% | +129.6% | -26.8% | -24.1% | -30.7% | +3.8% | -42.4% | +3.5% | |
| – | -7.8% | -21.9% | -23.3% | -13.4% | +129.6% | -26.8% | -24.1% | -30.7% | +3.8% | -42.4% | +3.5% | |
| – | – | – | – | – | – | -35.4% | -22.8% | -32.8% | -60.2% | +7.3% | +49,117.1% | |
| – | +46.1% | +3.6% | +71.1% | -13.5% | +111.8% | -31.4% | -8.7% | -19.5% | +17.4% | -32.9% | +40.6% | |
| – | +46.7% | +3.6% | +71.1% | -13.5% | +111.8% | -31.4% | -8.7% | -19.5% | +17.4% | -32.9% | +40.6% | |
| – | -14.6% | -29.0% | -42.0% | -74.6% | – | – | – | – | – | – | – | |
| – | +18.1% | +139.3% | +89.7% | -34.6% | +202.4% | -14.9% | -29.9% | -31.4% | +5.9% | +26.8% | +5.7% | |
| – | -12.0% | -19.5% | -35.5% | -14.5% | +118.0% | -17.8% | -29.7% | -36.4% | +0.1% | -34.4% | +127.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +23.2% | -0.3% | +3.4% | +38.1% | +20.9% | +6.4% | +4.2% | -2.5% | +20.8% | +21.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.